Browse > Article
http://dx.doi.org/10.1016/j.jgr.2019.12.001

Ginseng alleviates microbial infections of the respiratory tract: a review  

Iqbal, Hamid (School of Pharmacy, Sungkyunkwan University)
Rhee, Dong-kwon (School of Pharmacy, Sungkyunkwan University)
Publication Information
Journal of Ginseng Research / v.44, no.2, 2020 , pp. 194-204 More about this Journal
Abstract
The detrimental impact of air pollution as a result of frequent exposure to fine particles posed a global public health risk mainly to the pulmonary disorders in pediatric and geriatric population. Here, we reviewed the current literature regarding the role of ginseng and/or its components as antimicrobials, especially against pathogens that cause respiratory infections in animal and in vitro models. Some of the possible mechanisms for ginseng-mediated viral inhibition suggested are improvements in systemic and mucosa-specific antibody responses, serum hemagglutinin inhibition, lymphocyte proliferation, cell survival rate, and viral clearance in the lungs. In addition, ginseng reduces the expression levels of proinflammatory cytokines (IFN-γ, TNF-α, IL-2, IL-4, IL-5, IL-6, IL-8) and chemokines produced by airway epithelial cells and macrophages, thus preventing weight loss. In case of bacterial infections, ginseng acts by alleviating inflammatory cytokine production, increasing survival rates, and activating phagocytes and natural killer cells. In addition, ginseng inhibits biofilm formation and induces the dispersion and dissolution of mature biofilms. Most clinical trials revealed that ginseng, at various dosages, is a safe and effective method of seasonal prophylaxis, relieving the symptoms and reducing the risk and duration of colds and flu. Taken together, these findings support the efficacy of ginseng as a therapeutic and prophylactic agent for respiratory infections.
Keywords
Bacteria; Clinical trials; Ginseng; Respiratory tract infections; Virus;
Citations & Related Records
Times Cited By KSCI : 9  (Citation Analysis)
연도 인용수 순위
1 Miyashita N, Saito A, Kohno S, Yamaguchi K, Watanabe A, Oda H, Kazuyama Y, Matsushima T, CAP Study Group. Multiplex PCR for the simultaneous detection of Chlamydia pneumoniae, Mycoplasma pneumoniae and Legionella pneumophila in community-acquired pneumonia. Respir Med 2004;98(6):542-50.   DOI
2 Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet 2011;377(9773):1264-75.   DOI
3 Yu C, Wang CZ, Zhou CJ, Wang B, Han L, Zhang CF, Wu XH, Yuan CS. Adulteration and cultivation region identification of American ginseng using HPLC coupled with multivariate analysis. J Pharm Biomed Anal 2014;99:8-15.   DOI
4 Lee JS, Hwang HS, Ko EJ, Lee YN, Kwon YM, Kim MC, Kang SM. Immunomodulatory activity of red ginseng against influenza A virus infection. Nutrients 2014;6(2):517-29.   DOI
5 Pan Y, Wang X, Sun G, Li F, Gong X. Application of RAD sequencing for evaluating the genetic diversity of domesticated Panax notoginseng (Araliaceae). PLoS ONE 2016;11(11). e0166419.   DOI
6 McElhaney JE, Goel V, Toane B, Hooten J, Shan JJ. Efficacy of COLD-fX in the prevention of respiratory symptoms in community-dwelling adults: a randomized, double-blinded, placebo controlled trial. J Altern Complement Med 2006;12(2):153-7.   DOI
7 McElhaney JE, Simor AE, McNeil S, Predy GN. Efficacy and safety of CVT-E002, a proprietary extract of Panax quinquefolius in the prevention of respiratory infections in influenza-vaccinated community-dwelling adults: a multicenter, randomized, double-blind, and placebo-controlled trial. Influenza Res Treat 2011;2011:759051. https://doi.org/10.1155/2011/759051.
8 Seida JK, Durec T, Kuhle S. North American (Panax quinquefolius) and Asian ginseng (Panax ginseng) preparations for prevention of the common cold in healthy adults: a systematic review. Evid Based Complement Alternat Med 2011;2011:282151. https://doi.org/10.1093/ecam/nep068.
9 Yang L, Yu QT, Ge YZ, Zhang WS, Fan Y, Ma CW, Liu Q, Qi LW. Distinct urine metabolome after Asian ginseng and American ginseng intervention based on GC-MS metabolomics approach. Sci Rep 2016;6:39045.   DOI
10 Lee OR, Nguyen NQ, Lee KH, Kim YC, Seo J. Cytohistological study of the leaf structures of Panax ginseng Meyer and Panax quinquefolius L. J Ginseng Res 2017;41(4):463-8.   DOI
11 Borchers AT, Keen CL, Stern JS, Gershwin ME. Inflammation and Native American medicine: the role of botanicals. Am J Clin Nutr 2000;72(2):339-47.   DOI
12 Shergis JL, Di YM, Zhang AL, Vlahos R, Helliwell R, Ye JM, Xue CC. Therapeutic potential of Panax ginseng and ginsenosides in the treatment of chronic obstructive pulmonary disease. Complement Ther Med 2014;22(5):944-53.   DOI
13 Cui L, Wu SQ, Zhao CA, Yin CR. Microbial conversion of major ginsenosides in ginseng total saponins by Platycodon grandiflorum endophytes. J Ginseng Res 2016;40(4):366-74.   DOI
14 Lee JS, Ko EJ, Hwang HS, Lee YN, Kwon YM, Kim MC, Kang SM. Antiviral activity of ginseng extract against respiratory syncytial virus infection. Int J Mol Med 2014;34(1):183-90.   DOI
15 Lee JS, Cho MK, Hwang HS, Ko EJ, Lee YN, Kwon YM, Kim MC, Kim KH, Lee YT, Jung YJ, et al. Ginseng diminishes lung disease in mice immunized with formalin-inactivated respiratory syncytial virus after challenge by modulating host immune responses. J Interferon Cytokine Res 2014;34(11):902-14.   DOI
16 Becker S, Soukup J, Yankaskas JR. Respiratory syncytial virus infection of human primary nasal and bronchial epithelial cell cultures and bronchoalveolar macrophages. Am J Respir Cell Mol Biol 1992;6(4):369-74.   DOI
17 Lee JS, Lee YN, Lee YT, Hwang HS, Kim KH, Ko EJ, Kim MC, Kang SM. Ginseng protects against respiratory syncytial virus by modulating multiple immune cells and inhibiting viral replication. Nutrients 2015;7(2):1021-36.   DOI
18 Liu Q, Kou JP, Yu BY. Ginsenoside Rg1 protects against hydrogen peroxideinduced cell death in PC12 cells via inhibiting NF-kB activation. Neurochem Int 2011;58(1):119-25.   DOI
19 Jung ID, Kim HY, Park JW, Lee CM, Noh KT, Kang HK, Heo DR, Lee SJ, Son KH, Park HJ, et al. RG-II from Panax ginseng C.A. Meyer suppresses asthmatic reaction. BMB Rep 2012;45(2):79-84.   DOI
20 Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, Maccallum P, Meade TW, Jeffries DJ, Johnston SL, et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164(9):1618-23.   DOI
21 Schwela D. Air pollution and health in urban areas. Rev Environ Health 2000;15(1-2):13-42.   DOI
22 McElhaney JE, Gravenstein S, Cole SK, Davidson E, O'neill D, Petitjean S, Rumble B, Shan JJ. A placebo-controlled trial of a proprietary extract of North American ginseng (CVT-E002) to prevent acute respiratory illness in institutionalized older adults. J Am Geriatr Soc 2004;52(1):13-9.   DOI
23 Predy GN, Goel V, Lovlin R, Donner A, Stitt L, Basu TK. Efficacy of an extract of North American ginseng containing poly-furanosyl-pyranosyl-saccharides for preventing upper respiratory tract infections: a randomized controlled trial. CMAJ 2005;173(9):1043-8.   DOI
24 Vohra S, Johnston BC, Laycock KL, Midodzi WK, Dhunnoo I, Harris E, Baydala L. Safety and tolerability of North American ginseng extract in the treatment of pediatric upper respiratory tract infection: a phase II randomized, controlled trial of 2 dosing schedules. Pediatrics 2008;122(2):e402-10.   DOI
25 Heroux ME, Anderson HR, Atkinson R, Brunekreef B, Cohen A, Forastiere F, Hurley F, Katsouyanni K, Krewski D, Krzyzanowski M, et al. Quantifying the health impacts of ambient air pollutants: recommendations of a WHO/Europe project. Int J Public Health 2015;60(5):619-27.   DOI
26 Martino D, Prescott S. Epigenetics and prenatal influences on asthma and allergic airways disease. Chest 2011;139(3):640-7.   DOI
27 Kunzli N, Kaiser R, Medina S, Studnicka M, Chanel O, Filliger P, Herry M, Horak Jr F, Puybonnieux-Texier V, Quenel P, et al. Public-health impact of outdoor and traffic-related air pollution: a European assessment. Lancet 2000;356(9232):795-801.   DOI
28 WHO air quality guidelines for particulate matter, ozone, nitrogen dioxide and sulfur dioxide: global update 2005: summary of risk assessment. Geneva: World Health Organization; 2006.
29 Xue CC, Shergis JL, Zhang AL, Worsnop C, Fong H, Story D, Da Costa C, Thien FC. Panax ginseng C.A Meyer root extract for moderate chronic obstructive pulmonary disease (COPD): study protocol for a randomised controlled trial. Trials 2011;12:164. https://doi.org/10.1186/1745-6215-12-164.   DOI
30 Liu C, Chen R, Sera F, Vicedo-Cabrera AM, Guo Y, Tong S, Coelho MSZS, Saldiva PHN, Lavigne E, Matus P, et al. Ambient particulate air pollution and daily mortality in 652 cities. N Engl J Med 2019;381(8):705-15.   DOI
31 Wu L, Zhang AL, Di YM, Shergis JL, Chen Y, Guo X, Wen Z, Thien F, Worsnop C, Lin L, et al. Panax ginseng therapy for chronic obstructive pulmonary disease: a clinical trial protocol and pilot study. Chin Med 2014;9:20. https://doi.org/10.1186/1749-8546-9-20.   DOI
32 Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999;58(11):1685-93.   DOI
33 Nguyen NH, Nguyen CT. Pharmacological effects of ginseng on infectious diseases. Inflammopharmacology 2019. https://doi.org/10.1007/s10787-019-00630-4.
34 Park JD, Rhee DK, Lee YH. Biological activities and chemistry of saponins from Panax ginseng C. A. Meyer., Phytochemistry Reviews 2005;4:159-75.   DOI
35 Scaglione F, Ferrara F, Dugnani S, Falchi M, Santoro G, Fraschini F. Immunomodulatory effects of two extracts of Panax ginseng C.A. Meyer. Drugs Exp Clin Res 1990;16(10):537-42.
36 Choi KT. Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer. Acta Pharmacol Sin 2008;29(9):1109-18.   DOI
37 Helms S. Cancer prevention and therapeutics: Panax ginseng. Altern Med Rev 2004;9(3):259-74.
38 Kim WY, Kim JM, Han SB, Lee SK, Kim ND, Park MK, Kim CK, Park JH. Steaming of ginseng at high temperature enhances biological activity. J Nat Prod 2000;63(12):1702-4.   DOI
39 Yuan CS, Wang CZ, Wicks SM, Qi LW. Chemical and pharmacological studies of saponins with a focus on American ginseng. J Ginseng Res 2010;34(3):160-7.   DOI
40 Song X, Hu S. Adjuvant activities of saponins from traditional Chinese medicinal herbs. Vaccine 2009;27(36):4883-90.   DOI
41 Rivera E, Daggfeldt A, Hu S. Ginseng extract in aluminium hydroxide adjuvanted vaccines improves the antibody response of pigs to porcine parvovirus and Erysipelothrix rhusiopathiae. Vet Immunol Immunopathol 2003;91(1):19-27.   DOI
42 Song JH, Choi HJ, Song HH, Hong EH, Lee BR, Oh SR, Choi K, Yeo SG, Lee YP, Cho S, et al. Antiviral activity of ginsenosides against coxsackievirus B3, enterovirus 71, and human rhinovirus 3. J Ginseng Res 2014;38(3):173-9.   DOI
43 Jarjour NN, Gern JE, Kelly EA, Swenson CA, Dick CR, Busse WW. The effect of an experimental rhinovirus 16 infection on bronchial lavage neutrophils. J Allergy Clin Immunol 2000;105(6 Pt 1):1169-77.   DOI
44 Makris S, Johnston S. Recent advances in understanding rhinovirus immunity. F1000Resvol. 7; 2018. F1000 Faculty Rev-1537.
45 Zhu J, Message SD, Qiu Y, Mallia P, Kebadze T, Contoli M, Ward CK, Barnathan ES, Mascelli MA, Kon OM, et al. Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma. Chest 2014;145(6):1219-29.   DOI
46 Bucior I, Pielage JF, Engel JN. Pseudomonas aeruginosa pili and flagella mediate distinct binding and signaling events at the apical and basolateral surface of airway epithelium. PLoS Pathog 2012;8(4). e1002616.   DOI
47 Curran CS, Bolig T, Torabi-Parizi P. Mechanisms and targeted therapies for Pseudomonas aeruginosa lung infection. Am J Respir Crit Care Med 2018;197(6):708-27.   DOI
48 Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 2010;35(4):322-32.   DOI
49 Song Z, Kharazmi A, Wu H, Faber V, Moser C, Krogh HK, Rygaard J, Hoiby N. Effects of ginseng treatment on neutrophil chemiluminescence and immunoglobulin G subclasses in a rat model of chronic Pseudomonas aeruginosa pneumonia. Clin Diagn Lab Immunol 1998;5(6):882-7.   DOI
50 Gross D, Krieger D, Efrat R. Ginseng extract G115 for the treatment of chronic respiratory diseases. Scweiz Z Ganzheits Med 1995;1:29-33.
51 Scaglione F, Weiser K, Alessandria M. Effects of the standardised ginseng extract G115 in patients with chronic bronchitis: a nonblinded, randomised, comparative pilot study. Clin Drug Investig 2001;21:41-5. https://doi.org/10.2165/00044011-200121010-00006.   DOI
52 Scaglione F, Cogo R, Cocuzza C, Arcidiacono M, Beretta A. Immunomodulatory effects of Panax ginseng C.A. Meyer (G115) on alveolar macrophages from patients suffering with chronic bronchitis. Int J Immunother 1994;10:21-4.
53 Coon JT, Ernst E. Panax ginseng: a systematic review of adverse effects and drug interactions. Drug Saf 2002;25(5):323-44.   DOI
54 High KP, Case D, Hurd D, Powell B, Lesser G, Falsey AR, Siegel R, Metzner-Sadurski J, Krauss JC, Chinnasami B, et al. A randomized, controlled trial of Panax quinquefolius extract (CVT-E002) to reduce respiratory infection in patients with chronic lymphocytic leukemia. J Support Oncol 2012;10(5):195-201.   DOI
55 Scaglione F, Cattaneo G, Alessandria M, Cogo R. Efficacy and safety of the standardised ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the common cold [corrected]. Drugs Exp Clin Res 1996;22(2):65-72.
56 Brugha R, Grigg J. Urban air pollution and respiratory infections. Paediatr Respir Rev 2014;15(2):194-9. https://doi.org/10.1016/j.prrv.2014.03.001.   DOI
57 Heikkinen T, Jarvinen A. The common cold. Lancet 2003;361(9351):51-9.   DOI
58 Nichol KL. Improving influenza vaccination rates among adults. Cleve Clin J Med 2006;73(11):1009-15.   DOI
59 Chapman KR, Mannino DM, Soriano JB, Vermeire PA, Buist AS, Thun MJ, Connell C, Jemal A, Lee TA, Miravitlles M, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006;27(1):188-207.   DOI
60 Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997;349(9064):1498-504.   DOI
61 Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006;28(3):523-32.   DOI
62 Price D, Freeman D, Cleland J, Kaplan A, Cerasoli F. Earlier diagnosis and earlier treatment of COPD in primary care. Prim Care Respir J 2011;20(1):15-22.   DOI
63 World Health Organisation. Burden of COPD. Available from: http://www.who.int/respiratory/copd/burden/en/; 2014.
64 Graham BS. Biological challenges and technological opportunities for respiratory syncytial virus vaccine development. Immunol Rev 2011;239(1):149-66.   DOI
65 Neumann G, Chen H, Gao GF, Shu Y, Kawaoka Y. H5N1 influenza viruses: outbreaks and biological properties. Cell Res 2010;20(1):51-61.   DOI
66 Alipour M, Omri A, Suntres ZE. Ginseng aqueous extract attenuates the production of virulence factors, stimulates twitching and adhesion, and eradicates biofilms of Pseudomonas aeruginosa. Can J Physiol Pharmacol 2011;89(6):419-27.   DOI
67 Abramson M, Crockett AJ, Frith PA, Glasgow N, Jenkins S, McDonald CF, McKenzie DK, Wood-Baker R. The COPDX plan: Australian and New Zealand guidelines for the management of chronic obstructive pulmonary disease 2009. 2009. https://pdfs.semanticscholar.org/f4d3/23c5-688345b42916dc4b279fd2d6a598-9b.pdf.
68 Holgate ST, Polosa R. Treatment strategies for allergy and asthma. Nat Rev Immunol 2008;8(3):218-30.   DOI
69 Lynch JP, Zhanel GG. Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention. Semin Respir Crit Care Med 2009;30(2):189-209.   DOI
70 Yu J, Shi FS, Hu S. Improved immune responses to a bivalent vaccine of Newcastle disease and avian influenza in chickens by ginseng stem-leaf saponins. Vet Immunol Immunopathol 2015;167(3-4):147-55.   DOI
71 Murphy BR, Prince GA, Collins PL, Van Wyke Coelingh K, Olmsted RA, Spriggs MK, Parrott RH, Kim HW, Brandt CD, Chanock RM. Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial viruses. Virus Res 1988;11(1):1-15.   DOI
72 Kim HW, Canchola JG, Brandt CD, Pyles G, Chanock RM, Jensen K, Parrott RH. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol 1969;89(4):422-34.   DOI
73 Munoz FM. Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy? Curr Opin Infect Dis 2015;28(3):221-4.   DOI
74 Chan LY, Kwok HH, Chan RW, Peiris MJ, Mak NK, Wong RN, Chan MC, Yue PY. Dual functions of ginsenosides in protecting human endothelial cells against influenza H9N2-induced inflammation and apoptosis. J Ethnopharmacol 2011;137(3):1542-6.   DOI
75 Lee CS, Lee JH, Oh M, Choi KM, Jeong MR, Park JD, Kwon DY, Ha KC, Park EO, Lee N, et al. Preventive effect of Korean red ginseng for acute respiratory illness: a randomized and double-blind clinical trial. J Korean Med Sci 2012;27(12):1472-8.   DOI
76 World Health Organization. Fact sheets 211 influenza (seasonal) [Internet] Geneva. World Health Organization; 2016. Available from: http://www.who.int/mediacentre/factsheets/fs211/en.
77 Farooqui A, Lei Y, Wang P, Huang J, Lin J, Li G, Leon AJ, Zhao Z, Kelvin DJ. Genetic and clinical assessment of 2009 pandemic influenza in southern China. J Infect Dev Ctries 2011;5(10):700-10.   DOI
78 Dong W, Farooqui A, Leon AJ, Kelvin DJ. Inhibition of influenza A virus infection by ginsenosides. PLoS One 2017;12(2). e0171936.   DOI
79 Wang Y, Jung YJ, Kim KH, Kwon Y, Kim YJ, Zhang Z, Kang HS, Wang BZ, Quan FS, Kang SM. Antiviral activity of fermented ginseng Extracts against a broad range of influenza viruses. Viruses 2018;10(9). https://doi.org/10.3390/v10090471. E471.
80 Legg JP, Hussain IR, Warner JA, Johnston SL, Warner JO. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2003;168(6):633-9.   DOI
81 Garofalo RP, Kolli D, Casola A. Respiratory syncytial virus infection: mechanisms of redox control and novel therapeutic opportunities. Antioxid Redox Signal 2013;18(2):186-217.   DOI
82 Zhang Y, Luxon BA, Casola A, Garofalo RP, Jamaluddin M, Brasier AR. Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays. J Virol 2001;75(19):9044-58.   DOI
83 Blanco JC, Richardson JY, Darnell ME, Rowzee A, Pletneva L, Porter DD, Prince GA. Cytokine and chemokine gene expression after primary and secondary respiratory syncytial virus infection in cotton rats. J Infect Dis 2002;185(12):1780-5.   DOI
84 Mook-Kanamori BB, Geldhoff M, van der Poll T, van de Beek D. Pathogenesis and pathophysiology of pneumococcal meningitis. Clin Microbiol Rev 2011;24(3):557-91.   DOI
85 Song Z, Kong KF, Wu H, Maricic N, Ramalingam B, Priestap H, Schneper L, Quirke JM, Hoiby N, Mathee K. Panax ginseng has anti-infective activity against opportunistic pathogen Pseudomonas aeruginosa by inhibiting quorum sensing, a bacterial communication process critical for establishing infection. Phytomedicine 2010;17(13):1040-6.   DOI
86 Wu H, Lee B, Yang L, Wang H, Givskov M, Molin S, Hoiby N, Song Z. Effects of ginseng on Pseudomonas aeruginosa motility and biofilm formation. FEMS Immunol Med Microbiol 2011;62(1):49-56.   DOI
87 Song Z, Moser C, Wu H, Faber V, Kharazmi A, Hoiby N. Cytokine modulating effect of ginseng treatment in a mouse model of Pseudomonas aeruginosa lung infection. J Cyst Fibros 2003;2(3):112-9.   DOI
88 Nguyen CT, Luong TT, Lee SY, Kim GL, Kwon H, Lee HG, Park CK, Rhee DK. Panax ginseng aqueous extract prevents pneumococcal sepsis in vivo by potentiating cell survival and diminishing inflammation. Phytomedicine 2015;22(11):1055-61.   DOI
89 Yin SY, Kim HJ, Kim HJ. A comparative study of the effects of whole red ginseng extract and polysaccharide and saponin fractions on influenza A (H1N1) virus infection. Biol Pharm Bull 2013;36(6):1002-7.   DOI
90 Hwang J-H, Park S-H, Choi E-K, Jung S-J, Pyo MK, Chae S-W. A randomized, double-blind, placebo-controlled pilot study to assess the effects of protopanaxadiol saponineenriched ginseng extract and pectinase-processed ginseng extract on the prevention of acute respiratory illness in healthy people. J Ginseng Res 2019. https://www.sciencedirect.com/science/article/pii/S1226845318301519.
91 Quan FS, Compans RW, Cho YK, Kang SM. Ginseng and Salviae herbs play a role as immune activators and modulate immune responses during influenza virus infection. Vaccine 2007;25(2):272-82.   DOI
92 Wu H, Hoiby N, Yang L, Givskov M, Song Z. Effects of radix ginseng on microbial infections: a narrative review. J Tradit Chin Med 2014;34(2):227-33.   DOI
93 Song X, Chen J, Sakwiwatkul K, Li R, Hu S. Enhancement of immune responses to influenza vaccine (H3N2) by ginsenoside Re. Int Immunopharmacol 2010;10(3):351-6.   DOI
94 Kohanski MA, Dwyer DJ, Collins JJ. How antibiotics kill bacteria: from targets to networks. Nat Rev Microbiol 2010;8(6):423-35.   DOI
95 Wang M, Guilbert LJ, Ling L, Li J, Wu Y, Xu S, Pang P, Shan JJ. Immunomodulating activity of CVT-E002, a proprietary extract from North American ginseng (Panax quinquefolium). J Pharm Pharmacol 2001;53(11):1515-23.   DOI
96 Wang M, Guilbert LJ, Li J, Wu Y, Pang P, Basu TK, Shan JJ. A proprietary extract from North American ginseng (Panax quinquefolium) enhances IL-2 and IFNgamma productions in murine spleen cells induced by Con-A. Int Immunopharmacol 2004;4(2):311-5.   DOI
97 Ha KC, Kim MG, Oh MR, Choi EK, Back HI, Kim SY, Park EO, Kwon DY, Yang HJ, Kim MJ, et al. A placebo-controlled trial of Korean red ginseng extract for preventing influenza-like illness in healthy adults. BMC Complement Altern Med 2012;12:10.
98 Fonkwo PN. Pricing infectious disease. The economic and health implications of infectious diseases. EMBO Rep 2008;9(Suppl 1):S13-7. https://doi.org/10.1038/embor.2008.110.   DOI
99 Hament JM, Kimpen JL, Fleer A, Wolfs TF. Respiratory viral infection predisposing for bacterial disease: a concise review. FEMS Immunol Med Microbiol 1999;26(3-4):189-95.   DOI
100 Iroh Tam PY, Bernstein E, Ma X, Ferrieri P. Blood culture in evaluation of pediatric community-acquired pneumonia: a Systematic Review and Metaanalysis. Hosp Pediatr 2015;5(6):324-36.   DOI
101 Yoo DG, Kim MC, Park MK, Song JM, Quan FS, Park KM, Cho YK, Kang SM. Protective effect of Korean red ginseng extract on the infections by H1N1 and H3N2 influenza viruses in mice. J Med Food 2012;15(10):855-62.   DOI
102 Martin NG, Sadarangani M, Pollard AJ, Goldacre MJ. Hospital admission rates for meningitis and septicaemia caused by Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae in children in England over five decades: a population-based observational study. Lancet Infect Dis 2014;14(5):397-405.   DOI
103 Warhurst G, Dunn G, Chadwick P, Blackwood B, McAuley D, Perkins GD, McMullan R, Gates S, Bentley A, Young D, et al. Rapid detection of healthcare- associated bloodstream infection in critical care using multipathogen real-time polymerase chain reaction technology: a diagnostic accuracy study and systematic review. Health Technol Assess 2015;19(35):1-142.   DOI
104 Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File Jr TM, Musher DM, Niederman MS, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44(Suppl 2):S27-72.   DOI
105 Ritchie AI, Farne HA, Singanayagam A, Jackson DJ, Mallia P, Johnston SL. Pathogenesis of viral infection in exacerbations of airway disease. Ann Am Thorac Soc 2015;12(Suppl 2):S115-32. https://doi.org/10.1513/AnnalsATS.201503-151AW.
106 Cox JC, Coulter AR. Adjuvants-a classification and review of their modes of action. Vaccine 1997;15(3):248-56.   DOI
107 Xu ML, Kim HJ, Choi YR, Kim HJ. Intake of Korean red ginseng extract and saponin enhances the protection conferred by vaccination with inactivated influenza a virus. J Ginseng Res 2012;36(4):396-402.   DOI
108 Schwarze J, Mackenzie KJ. Novel insights into immune and inflammatory responses to respiratory viruses. Thorax 2013;68(1):108-10.   DOI
109 Park EH, Yum J, Ku KB, Kim HM, Kang YM, Kim JC, Kim JA, Kang YK, Seo SH. Red Ginseng-containing diet helps to protect mice and ferrets from the lethal infection by highly pathogenic H5N1 influenza virus. J Ginseng Res 2014;38(1):40-6.   DOI
110 Yoo DG, Kim MC, Park MK, Park KM, Quan FS, Song JM, Wee JJ, Wang BZ, Cho YK, Compans RW, et al. Protective effect of ginseng polysaccharides on influenza viral infection. PLoS One 2012;7(3). e33678.   DOI
111 Zhai L, Li Y, Wang W, Hu S. Enhancement of humoral immune responses to inactivated Newcastle disease and avian influenza vaccines by oral administration of ginseng stem-and-leaf saponins in chickens. Poult Sci 2011a;90(9):1955-9.   DOI
112 Zhai L, Li Y, Wang W, Wang Y, Hu S. Effect of oral administration of ginseng stem-and-leaf saponins (GSLS) on the immune responses to Newcastle disease vaccine in chickens. Vaccine 2011b;29(31):5007-14.   DOI